Accessibility StatementSkip Navigation NEW YORK and NEW ORLEANS, Sept. 26, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilNovember 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against V.F. Corporation. (NYSE: VFC), if they purchased or otherwise acquired VFC securities between October 30, 2023 and May 20, 2025, inclusive (the "Class Period"). This actio ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In PubMatic To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in PubMatic between February 27, 2025 and August 11, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330Â (Ext. 1310). To learn more about the PubMatic class acti ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lockheed Martin To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Lockheed Martin between January 23, 2024 and July 21, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247- 4292 or 212-983-9330Â (Ext. 1310). [You may also click here for ad ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In CTO To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in CTO between February 18, 2021 and June 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] ...

公司业务与运营 - 公司因旧版Payeezy平台存在成本问题及其他缺陷 强制要求商户迁移至Clover平台[6] - Clover平台收入增长和总支付量(GPV)因强制迁移而暂时性不可持续地提升 掩盖了新商户业务增速放缓的事实[6] - 大量原Payeezy商户因Clover定价过高 系统频繁宕机及兼容性问题 在迁移后转向竞争对手解决方案[6] 财务表现与市场反应 - 2025年第一季度Clover平台GPV增长率骤降至8% 较2024年14%-17%的增长率出现显著下滑[7] - 公司股价在2025年4月24日暴跌18.5%至每股176.90美元 因披露GPV增长放缓与Payeezy转化商户交易量下降相关[7] - 2025年5月15日股价再度下跌16.2%至每股159.13美元 公司确认GPV增长减速将贯穿2025全年[7] - 2025年7月23日公司下调全年有机增长指引上限 商户部门季度有机收入同比增速从11%降至9% 导致股价下跌13.9%至每股143.00美元[7] 法律与监管事项 - 公司被指控在2024年7月24日至2025年7月22日期间发布关于Clover增长策略 竞争地位 客户流失率及业务前景的虚假误导性陈述[6] - 联邦证券集体诉讼的牵头原告申请截止日期为2025年9月22日 涉及违反证券法的指控[4]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Charter To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Charter between July 26, 2024 and July 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE NE ...

公司事件 - 律师事务所Faruqi & Faruqi正在调查Unicycive Therapeutics公司 并提醒投资者在2025年10月14日前申请成为集体诉讼的首席原告[4] - 诉讼指控公司及高管违反联邦证券法 通过做出虚假和/或误导性陈述及/或未能披露相关信息[6] - 指控具体内容包括公司夸大其满足FDA生产合规要求的能力 以及夸大OLC新药申请的监管前景[6] 监管进展 - 2025年6月10日公司披露FDA在其第三方制造供应商处发现cGMP合规缺陷 导致无法进行标签讨论[7] - 此消息导致公司股价下跌3.68美元 跌幅达40.89% 收盘价为5.32美元[7] - 2025年6月30日FDA针对OLC新药申请发出完整回复函 再次提及先前发现的cGMP缺陷[8] - 此消息导致公司股价进一步下跌2.03美元 跌幅达29.85% 收盘价为4.77美元[8] 投资者影响 - 诉讼涵盖期间为2024年3月29日至2025年6月27日 针对损失超过50,000美元的投资者[1] - 法院指定的首席原告将是集体成员中财务利益最大且具有代表性的投资者[9] - 投资者可选择通过律师申请成为首席原告 或保持缺席集体成员身份[9]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIR ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Replimune between November 22, 2024 and July 21, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GL ...

公司财务与经营状况 - CTO的股息可持续性低于公司管理层向投资者传达的水平 [5] - 公司使用欺骗性和不可持续的做法人为抬高其调整后运营资金(AFFO)并夸大其Ashford Lane物业的真实盈利能力 [5] - 自2021年转为REIT以来，公司未能产生足够现金支付经常性资本支出和股息，依赖股份稀释来弥补2021至2024年间3800万美元的股息缺口 [6] - 公司现金仅840万美元，但面临每季度1400万美元的股息支出和570万美元的平均经常性资本支出，另有约1200万美元的额外计划资本支出 [6] 市场反应与股价表现 - 2025年6月25日Wolfpack研究报告发布后，公司股价下跌0.98美元，跌幅5.42%，收于17.10美元 [7] - Wolfpack报告将CTO与B Riley进行不利比较，后者近年价值下跌超过90%，并面临SEC调查 [6] 法律与监管事项 - 联邦证券集体诉讼指控公司及其高管违反证券法，做出虚假和误导性陈述 [3][5] - 诉讼指控公司未能披露股息可持续性问题、使用不当会计方法夸大盈利能力以及业务前景被高估等情况 [5] - 投资者需在2025年10月7日前申请成为首席原告 [3] 公司治理与信息披露 - Wolfpack报告指控公司使用"操纵性AFFO定义"，将经常性资本支出排除在外，这与同行做法不符 [6] - 公司被指控使用虚假贷款隐瞒Ashford Lane物业主要租户崩溃的情况 [6]